Sale!

SPG21 Gene SPG21 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SPG21 gene is associated with a rare disorder known as Mast Syndrome, a form of hereditary spastic paraplegia (HSP). This condition is characterized by progressive weakness and spasticity of the legs, leading to severe mobility issues and other neurological symptoms. The SPG21 genetic test is a crucial diagnostic tool designed to detect mutations in the SPG21 gene, confirming the diagnosis of Mast Syndrome and aiding in the management and treatment planning for affected individuals.

Conducted at DNA Labs UAE, a leading facility in genetic testing, the SPG21 genetic test involves analyzing the patient’s DNA to look for specific mutations in the SPG21 gene that are known to cause the disorder. This test is essential for families with a history of Mast Syndrome, as it can provide valuable information for genetic counseling and future family planning.

The cost of the SPG21 genetic test at DNA Labs UAE is 4400 AED. This price includes the full process of sample collection, DNA analysis, and a comprehensive report detailing the results and their implications. Given the complexity of genetic testing and the expertise required to interpret the results accurately, the cost reflects the high level of service and reliability offered by DNA Labs UAE.

In summary, the SPG21 genetic test is a specialized diagnostic tool available at DNA Labs UAE, aimed at individuals and families affected by or at risk of Mast Syndrome. At a cost of 4400 AED, this test offers a pathway to understanding and managing this rare genetic disorder more effectively.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SPG21 Gene SPG21 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SPG21 Gene SPG21 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SPG21 Gene SPG21

Test Details

The SPG21 gene is associated with a rare genetic disorder called hereditary spastic paraplegia type 21 (SPG21). This disorder is characterized by progressive muscle stiffness and weakness in the lower limbs, leading to difficulty walking.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of SPG21, NGS genetic testing can be used to identify mutations or variations in the SPG21 gene that may be responsible for causing hereditary spastic paraplegia type 21.

By identifying these genetic changes, NGS genetic testing can help confirm a diagnosis of SPG21 and provide important information for genetic counseling and management of the condition. It can also be used for carrier testing in individuals with a family history of SPG21, as well as for prenatal or preimplantation genetic diagnosis in at-risk pregnancies.

Overall, SPG21 NGS genetic testing plays a crucial role in the diagnosis and management of hereditary spastic paraplegia type 21, allowing for personalized treatment and family planning options.

Test Name SPG21 Gene SPG21 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SPG21 Gene SPG21 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SPG21 Gene SPG21
Test Details

The SPG21 gene is associated with a rare genetic disorder called hereditary spastic paraplegia type 21 (SPG21). This disorder is characterized by progressive muscle stiffness and weakness in the lower limbs, leading to difficulty walking.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of SPG21, NGS genetic testing can be used to identify mutations or variations in the SPG21 gene that may be responsible for causing hereditary spastic paraplegia type 21.

By identifying these genetic changes, NGS genetic testing can help confirm a diagnosis of SPG21 and provide important information for genetic counseling and management of the condition. It can also be used for carrier testing in individuals with a family history of SPG21, as well as for prenatal or preimplantation genetic diagnosis in at-risk pregnancies.

Overall, SPG21 NGS genetic testing plays a crucial role in the diagnosis and management of hereditary spastic paraplegia type 21, allowing for personalized treatment and family planning options.